Skip navigation
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYermack, David-
dc.date.accessioned2008-05-30T08:06:02Z-
dc.date.available2008-05-30T08:06:02Z-
dc.date.issued1995-12-
dc.identifier.urihttp://hdl.handle.net/2451/27145-
dc.description.abstractThis paper analyzes company disclosures of CEO stock option values in compliance with the SEC’s regulations for reporting executive compensation data to stockholders. Companies appear to exploit the flexibility of the regulations to reduce the apparent value of managerial compensation. Companies shorten the expected lives of stock options and unilaterally apply discounts to the Black-Scholes formula. Theoretical support for these adjustments is often thin, and companies universally ignore reasons that the Black-Scholes formula might underestimate the value of executive stock options. The findings not only cast light upon how corporations value executive stock options, but also provide a means of forecasting compliance with controversial new FASB requirements for firms to disclose the compensation expense represented by executive stock options.en
dc.language.isoen_USen
dc.relation.ispartofseriesFIN-95-034en
dc.subjectExecutive stock optionsen
dc.subjectDisclosureen
dc.subjectValuationen
dc.titleCompanies' Modest Claims About the Value of CEO Stock Option Awardsen
dc.typeWorking Paperen
Appears in Collections:Finance Working Papers

Files in This Item:
File Description SizeFormat 
wpa95034.pdf1.4 MBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.